Click on the Item Code to purchase the Archive
Archive Item Code: 3800-H
Item Name: Systematic Approach to FNA Diagnosis of Metastatic Neoplasms
Yun Gong, MD
Presentation date: November 22, 2016; Expires: November 22, 2019
This presentation provides a road map with which to navigate the thought process in reaching a proper final FNA diagnosis. The main framework of diagnostic approach includes metastatic pattern, morphologic pattern, and immunophenotypic pattern. A systematic, tired algorithm is well outlined in immunoperoxidase workup. The pitfalls or traps that may be encountered in daily practice are emphasized and the solutions or tips are provided.
Archive Item Code: 3800-D
Item Name: Role of Touch Imprint Cytology of Needle Core Biopsies in Adequacy Assessment: Change in Practice Pattern
Vijayalakshmi Padmanabhan, MD
Presentation date: July 26, 2016; Expires: July 26, 2019
Needle core biopsies (NCB) are replacing classic FNA in many institutions across the US, and intra-procedural cytological assessment of the Touch Imprint (TI) cytology of NCB is often requested by radiologists. In this webinar, we will discuss the role of TI cytology of skinny NCB in adequacy assessment – preparing the specimen, differentiating the morphological features from classic FNA and the advantages and pitfalls of this technique.
Archive Item Code: 3600-B
Item Name: Next Generation Sequencing and Cytopathology: The Future is Now
Cory Bernardt, MD, PhD
Presentation Date: May 27, 2014; Expires: May 27, 2017
Molecular testing of cancer is increasingly critical to medicine. The development of targeted therapeutics has brought the concept of personalized medicine to the forefront. Next-generation sequencing (NGS) is proving to be a powerful tool for identifying diverse genetic mutations across numerous genes. Cytology specimens, particularly fine needle aspirations, are typically the first, and often the only, specimen available for diagnosis and ancillary testing. This webinar will introduce NGS, and describe how cytology specimens can be utilized for NGS to improve patient care.
Archive Item Code: 3600-E
Item Name: Pap Test and HPV Correlation: The Value of Morphology
Barbara McGahey Frain, MS, CT(ASCP)
Presentation date: August 26, 2014; Expires: August 26, 2017
The focus of this archive will be a case-based approach to Pap Tests with expected, as well as unexpected high risk HPV results. Clinical/histologic follow up will be provided. Some unusual conditions will be addressed. Technical considerations and trouble-shooting based on one organization’s experience will be included.
Archive Item Code: 3500-J
Item Name: Exfoliative Cytology of the Extrahepatic Biliary Tract: Morphologic Assessment and Ancillary Testing
Lester J. Layfield, MD
Presentation Date: January 28, 2014; Expires: January 28, 2017
The morphologic features of extrahepatic biliary tract malignancies can be subtle and the implications of such a diagnosis are significant. This webinar reviews the diagnostic criteria for the diagnosis of adenocarcinoma in exfoliative samples and provides information on ancillary molecular testing.
Archive Item Code: 3500-F
Item Name: Diagnostic Approach to Lymphoproliferative Neoplasms in Cytology Specimens
Oscar Lin, MD, PhD
Presentation Date: September 24, 2013; Expires: September 24, 2016
Lymphoproliferative lesions are commonly seen in cytology specimens, including needle aspirations as well as exfoliative cytology. Accurate diagnosis of these lesions requires correlation of the morphologic findings with ancillary studies and clinical findings. Knowledge of the limitations in cytology cases is important to avoid unnecessary work up and misinterpretation. The objective of this presentation is to provide a methodological approach to lymphoproliferative lesions in cytology specimens.
Item Code: 3500-C
Item Name: Integration of Molecular Ancillary Techniques into Routine Cytology Practice: Issues in Current State of the Art and Critical Future Trends
Stewart M. Knoepp, MD, PhD
Presentation Date: June 25, 2013; Expires: June 25, 2016
First, a brief overview of important molecular tests for cytologic specimens will be discussed. Information provided will be based on ordering, practice patterns, and experience at a large academic medical center, a multi-state private co-tenancy laboratory, and extensive literature review.
Next, an optimized approach for triaging cytologic tissue for accurate cytologic diagnosis as well as the performance of clinically relevant ancillary studies will be presented. Selected clinical scenarios and molecular tests will be discussed.
Lastly, the future need for optimization of molecular testing on cytology specimens in a coordinated-care environment (e.g. accountable care organizations) will be discussed.